Integra introduces new motorized tip spacing pipettes
![](/46/pdcnewsitem/04/23/22/ibspr197-image.jpg)
The VOYAGER II is the only commercially available pipette range where the tip spacing can be changed electronically,
Integra has launched a new generation version of its popular VOYAGER pipette range that features unique motorized tip spacing technology.
At the push of a button, VOYAGER II pipettes allow users to expand tip spacing anywhere between 4.5 mm and 33 mm (depending on the model). This enables rapid and optimised multichannel pipetting between microplates, tube racks and gel boxes of different sizes and formats.
The VOYAGER II pipette incorporates a new 135-degree rotatable body enabling users to always hold the pipette in a comfortable working position. Additionally, the reduced weight of the VOYAGER II facilitates easy, unstrained pipetting even over prolonged sessions. The updated design features even better accuracy and precision, especially at low volumes. The VOYAGER II introduces a new highly intuitive multilingual user interface operating across all menus. To enhance productivity the VOYAGER II can save up to 40 individual custom programs thereby accelerating the implementation of often repeated pipetting protocols.
Available in 4-, 6-, 9- and 12-channel versions, the VOYAGER II is the only commercially available pipette range where the tip spacing can be changed electronically. Using a VOYAGER II pipette the number of transfer steps, compared with using single channel pipettes, can be significantly reduced. This results in considerable time savings and less error prone sample processing. Using a VOYAGER II, pipetting protocols can be finished up to 12 times faster compared with a traditional single channel pipette. In addition to increasing the productivity of your liquid sample transfers, a VOYAGER II pipette allows the user to change tip spacing single handed thereby leaving their other hand free to handle the sample vessel.
Benefiting from a high precision motor, the VOYAGER II tip movement can be exactly controlled and the required tip-to-tip spacing for lab protocols saved for future repeat use. Up to three different tip-to-tip spacings can be saved and later be accessed anytime during a pipetting protocol.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance